Core Viewpoint - Recently, Ruiley Medical Beauty announced a subscription agreement with Miao Shi Aesthetics, investors, shareholders, and the target company, Laili Medical Beauty, indicating a strategic move to expand its business in Hong Kong and enhance financial performance through synergies [1] Group 1: Subscription Agreement Details - Ruiley Medical Beauty's indirect non-wholly owned subsidiary will subscribe for 170,000 shares of Laili Medical Beauty for HKD 2.55 million, acquiring a 51.0% stake [1] - Bifu Limited will subscribe for 63,300 shares for HKD 0.95 million, holding a 19.0% stake, while Miao Shi Aesthetics will hold a 30.0% stake [1] - Following the completion of the agreement, Laili Medical Beauty will become an indirect non-wholly owned subsidiary of Ruiley Medical Beauty, with its financial performance consolidated into the group’s accounts [1] Group 2: Business Strategy and Expectations - The board believes that the subscription aligns with the group's business expansion strategy and presents an opportunity to enhance operations in Hong Kong [1] - The expected improvement in the operational and financial performance of the target company could provide potential investment returns for the group [1]